The companies announce the first emergency approval of their mRNA vaccine against COVID-19, with rollout to begin next week.

The companies announce the first emergency approval of their mRNA vaccine against COVID-19, with rollout to begin next week.
US company second to report impressive efficacy for its COVID-19 vaccine candidate.
Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.
Three laureates share this year’s Nobel prize in physics for their discoveries about one of the most exotic phenomena in the universe: the black hole.
This year’s Nobel Prize in Physiology or Medicine recognizes the achievements made in identifying and treating hepatitis C.
A small trial indicates that Moderna’s experimental SARS-CoV-2 vaccine is effective and safe in older adults, a population group most vulnerable to severe COVID-19.
Czech researchers developed self-propelled microrobots that decompose complex solid pollutants, such as single use and disposable textile fibers.
Guano stains on sea ice reveal 11 new emperor penguin colonies in Antarctica.
Studies find social media sharing affects news judgment, but a quick exercise reduces the problem.
The interaction between the innate and the adaptive immune responses to COVID-19 may be impacting disease progression, and the answer might be to suppress them.